Vaccine and Cellular Immunology Laboratory, Chulalongkorn Medical Research Center (ChulaMRC), and Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
PLoS One. 2011;6(8):e23603. doi: 10.1371/journal.pone.0023603. Epub 2011 Aug 22.
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversity of HIV-1 represents a critical hurdle to developing an effective HIV-1 vaccine, and it is likely that regional-specific vaccine strains will be required to overcome the diversity of the different HIV-1 clades distributed world-wide. Unfortunately, little is known about the CD8+ T cell responses against CRF01_AE, which is responsible for the majority of infections in Southeast Asia.
METHODOLOGY/PRINCIPAL FINDINGS: To identify dominant CD8+ T cell responses recognized in HIV-1 clade CRF01_AE infected subjects we drew upon data from an immunological screen of 100 HIV-1 clade CRF01_AE infected subjects using IFN-gamma ELISpot to characterize a novel immunodominant CD8+ T cell response in HIV-1 Gag restricted by HLA-Cw0102 (p24, (277)YSPVSILDI(285), YI9). Over 75% of Cw0102+ve subjects targeted this epitope, representing the strongest response in more than a third of these individuals. This novel CD8 epitope was located in a highly conserved region of HIV-1 Gag known to contain immunodominant CD8 epitopes, which are restricted by HLA-B57 and -B27 in clade B infection. Nonetheless, viral escape in this epitope was frequently observed in Cw*0102+ve subjects, suggestive of strong selection pressure being exerted by this common CD8+ T cell response.
CONCLUSIONS/SIGNIFICANCE: As HLA-Cw0102 is frequently expressed in the Thai population (allelic frequency of 16.8%), this immunodominant Cw0102-restricted Gag epitope may represent an attractive candidate for vaccines specific to CRF01_AE and may help facilitate further studies of immunopathogenesis in this understudied HIV-1 clade.
CD8+T 细胞反应在控制 HIV-1 中起着重要作用。HIV-1 的广泛序列多样性是开发有效 HIV-1 疫苗的一个关键障碍,很可能需要针对分布在世界各地的不同 HIV-1 群的区域特异性疫苗株来克服这种多样性。不幸的是,人们对负责东南亚大部分感染的 HIV-1 流行株 CRF01_AE 的 CD8+T 细胞反应知之甚少。
方法/主要发现:为了鉴定感染 HIV-1 流行株 CRF01_AE 的个体中识别出的主要 CD8+T 细胞反应,我们利用来自 100 名感染 HIV-1 流行株 CRF01_AE 的个体的免疫筛选数据,通过 IFN-γ ELISpot 来描述 HIV-1 Gag 中由 HLA-Cw0102 限制的新型免疫优势 CD8+T 细胞反应(p24,(277)YSPVSILDI(285),YI9)。超过 75%的 Cw0102+ve 个体针对该表位,这是这些个体中超过三分之一的最强反应。这个新的 CD8 表位位于 HIV-1 Gag 的一个高度保守区域,已知该区域包含免疫优势 CD8 表位,这些表位在 B 群感染中由 HLA-B57 和 -B27 限制。尽管如此,在 Cw*0102+ve 个体中经常观察到该表位的病毒逃逸,提示这种常见的 CD8+T 细胞反应受到强烈的选择压力。
结论/意义:由于 HLA-Cw0102 在泰国人群中频繁表达(等位基因频率为 16.8%),因此这种免疫优势的 Cw0102 限制性 Gag 表位可能是针对 CRF01_AE 的疫苗的有吸引力的候选物,并可能有助于促进对这一研究不足的 HIV-1 群的免疫发病机制的进一步研究。